))
Hold the Haldol: Exploring the Role of Cholinergics in Schizophrenia
Manage episode 287011775 series 2866905
Konten disediakan oleh Daniel Fuchs, Gedaliah May, Steven Gamss, Produced by Daniel Miller, Daniel Fuchs, Gedaliah May, Steven Gamss, and Produced by Daniel Miller. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Daniel Fuchs, Gedaliah May, Steven Gamss, Produced by Daniel Miller, Daniel Fuchs, Gedaliah May, Steven Gamss, and Produced by Daniel Miller atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Until now, schizophrenia and other psychotic diseases were consistently treated with heavy duty, anti-dopaminergic, anti-psychotic medications. These drugs- both first and second generation- carry serious and sometimes irreversible adverse effects (think: EPS, NMS, etc.)
In today’s episode, we’ll discuss a groundbreaking phase-2 clinical trial exploring the use of a muscarinic agonist in the treatment of schizophrenia. Worried about DUMBBELLS? So were we! But these researchers have designed a truly elegant cholinergic/anti-cholinergic duet.
This is an exciting article you don’t want to miss out on!
27 episode
Bagikan
